During the past decade, David C. Pratt Cancer Center at St. John's Mercy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 39 clinical trials were completed, i.e. on average, 975% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "David C. Pratt Cancer Center at St. John's Mercy" #1 sponsor was "SWOG Cancer Research Network" with 37 trials, followed by "Radiation Therapy Oncology Group" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "Eastern Cooperative Oncology Group" with 6 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "David C. Pratt Cancer Center at St. John's Mercy" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "David C. Pratt Cancer Center at St. John's Mercy" are "Breast Cancer" (21 trials), "Lung Cancer" (10 trials), "Prostate Cancer" (9 trials), "Leukemia" (7 trials) and "Head and Neck Cancer" (6 trials). Many other conditions were trialed in "David C. Pratt Cancer Center at St. John's Mercy" in a lesser frequency.

Most popular intervention types in "David C. Pratt Cancer Center at St. John's Mercy" are "Drug" (61 trials), "Radiation" (20 trials), "Biological" (17 trials), "Other" (15 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (11 trials), "paclitaxel" (11 trials), "cyclophosphamide" (9 trials), "docetaxel" (9 trials) and "radiation therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "David C. Pratt Cancer Center at St. John's Mercy" are 52 trials for "All" genders, 20 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "David C. Pratt Cancer Center at St. John's Mercy". undefined are not yet recruiting, 1 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in David C. Pratt Cancer Center at St. John's Mercy, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in David C. Pratt Cancer Center at St. John's Mercy, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".